Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00103
|
|||||
Drug Name |
Ethinyl estradiol
|
|||||
Synonyms |
17 alpha-Ethinylestradiol; 17 alpha-Ethynylestradiol; 17 alpha-Ethynyloestradiol; 17 alpha-ethinyestradiol; 17-Ethinyl-3,17-estradiol; 17-Ethinyl-3,17-oestradiol; 17-Ethinylestradiol; 17-Ethynylestradiol; 17-Ethynyloestradiol; 17-alpha-Ethinyl-17-beta-estradiol; 17-alpha-Ethynyl-17-beta-oestradiol; 17-alpha-Ethynylestradiol; 17-alpha-Ethynylestradiol-17-beta; 17-alpha-Ethynylestradiol-l7-beta; 17-alpha-Ethynyloestradiol-17-beta; 17-alpha-ethynyl estradiol; 17.alpha.-Ethinyl-17.beta.-estradiol; 17.alpha.-Ethinylestradiol; 17.alpha.-Ethynyl-17.beta.-oestradiol; 17.alpha.-Ethynylestradiol; 17.alpha.-Ethynyloestradiol; 17a-Ethynylestradiol; 17alpha-Ethinyl estradiol; 17alpha-Ethinylestradiol; 17alpha-Ethinylestradiol-17beta; 17alpha-Ethynylestradiol; 17alpha-Ethynyloestradiol; 17alpha-Ethynyloestradiol-17beta; Aethinyloestradiolum; Aethinyoestradiol; Aethinyoestradiol [German]; Amenoron; Amenorone; Anovlar; Certostat; Chee-O-Gen; Chee-O-Genf; Component of Demulen; Component of Oracon; Component of Ortrel; Cyclosa; Dicromil; Diognat-E; Diogyn E; Diogyn-E; Diprol; Dyloform; EE(sub 2); EE2; ETHINYLESTRADIOL; Effik Brand of Ethinyl Estradiol; Ertonyl; Esteed; Estigyn; Estinyl; Estinyl (TN); Eston-E; Estopherol; Estoral; Estoral (Orion); Estoral (VAN);Estradiol, Ethinyl; Estoral [Orion]; Estorals; Estradiol, Ethynyl; Ethidol; Ethinoral; Ethinyl E2; Ethinyl Estradiol Hemihydrate; Ethinyl Estradiol [USP]; Ethinyl Estradiol, (8 alpha)-Isomer; Ethinyl Oestradiol Effik; Ethinyl estradiol (USP); Ethinyl-Oestradiol Effik; Ethinyl-oestranol; Ethinylestradiol (JP15/INN); Ethinylestradiol Jenapharm; Ethinylestradiol [INN:BAN:JAN]; Ethinylestradiolum; Ethinylestradiolum [INN-Latin]; Ethinylestriol; Ethinyloestradiol; Ethinyloestradiol [Steroidal oestrogens]; Ethy 11; Ethynyl estradiol; Ethynylestradiol; Ethynylestradiol, Ethinyl Estradiol; Ethynyloestradiol; Eticyclin; Eticyclol; Eticylol; Etinestrol; Etinestryl; Etinilestradiol; Etinilestradiol [INN-Spanish]; Etinilestradiolo; Etinilestradiolo [DCIT]; Etinoestryl; Etistradiol; Etivex; Feminone; Follicoral; Ginestrene; Hemihydrate, Ethinyl Estradiol; Inestra; Jenapharm Brand of Ethinyl Estradiol; Jenapharm, Ethinylestradiol; Kolpolyn; Linoral; Lynoral;Menolyn; Microfollin; Microfollin Forte; Neo-Estrone; Nogest-S; Novestrol; OVULEN-21; OVULEN-28; Oradiol; Orestralyn; Orestrayln; Organon Brand of Ethinyl Estradiol; Ortho-Cyclen; PUBERTAL ETHINYL ESTRADIOL STUDY; Palonyl; Perovex; Primogyn; Primogyn C; Primogyn M; Progynon C; Progynon M; Prosexol; Schering Brand of Ethinyl Estradiol; Spanestrin; Ylestrol
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Female hypogonadism [ICD11:5A61.0] | Approved | [1] | |||
Therapeutic Class |
Estrogens
|
|||||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C20H24O2
|
|||||
Canonical SMILES |
CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O
|
|||||
InChI |
InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1
|
|||||
InChIKey |
BFPYWIDHMRZLRN-SLHNCBLASA-N
|
|||||
CAS Number |
CAS 57-63-6
|
|||||
Pharmaceutical Properties | Molecular Weight | 296.4 | Topological Polar Surface Area | 40.5 | ||
Heavy Atom Count | 22 | Rotatable Bond Count | 1 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 2 | |||
XLogP |
3.7
|
|||||
PubChem CID | ||||||
PubChem SID |
11404629
,11533305
,14898199
,14922735
,17389896
,24702258
,24714981
,24869989
,24894585
,26512288
,26719638
,26753042
,29215113
,29225006
,46386858
,46508618
,48413731
,48415973
,48421874
,48423390
,48425117
,49854450
,53788253
,56311124
,56311183
,56311332
,56311399
,56311403
,56311406
,56311535
,56312680
,56313453
,56313621
,56313838
,56313881
,56314241
,57288591
,57650750
,71821446
,76025
,78032044
,7847620
,7979198
,81093168
,8139942
,8153725
,92308409
,92713395
,93165614
,9737
|
|||||
ChEBI ID |
ChEBI:4903
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Ethinyl estradiol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro. Pharm Res. 2004 Jul;21(7):1284-93. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.